• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Antiviral effect of ?Kagocel? substance in vitro on influenza viruses H1N1, H1N1pdm09 and H3N2

tetano

Editor, Senior Moderator
Vopr Virusol. 2019;64(3):125-131. doi: 10.18821/0507-4088-2019-64-3-125-131. [h=1][Antiviral effect of ?Kagocel? substance in vitro on influenza viruses H1N1, H1N1pdm09 and H3N2.][/h]
[Article in Russian]

Fediakina IT[SUP]1[/SUP], Konopleva MV[SUP]1[/SUP], Proshina ES[SUP]1[/SUP], Linnik EV[SUP]1[/SUP], Nikitina NI[SUP]1[/SUP].
[h=3]Author information[/h] 1 N.F. Gamaleya National Research Centre for Epidemiology and Microbiology, Moscow, 123098, Russian Federation.

[h=3]Abstract[/h] [h=4]INTRODUCTION:[/h] Active circulation of pandemic influenza and new variants of influenza H3N2 strains requires monitoring of antiviral efficacy of drugs permitted for influenza therapy in the Russian Federation.
[h=4]PURPOSE:[/h] Assessment of antiviral efficacy of ?Kagocel? substance against influenza viruses H1N1, H1N1pdm09 and H3N2 in vitro.
[h=4]MATERIAL AND METHODS:[/h] Cytotoxic effect of ?Kagocel? substance on MDCK cells had been determined by stained with MTS. Antiviral efficacy of ?Kagocel? substance against influenza infection has been studied in vitro in the culture of MDCK cells infected with influenza virus strains: A/Puerto Rico/8/34 (H1N1), А/California/7/2009 (H1N1)pdm09, А/Hong Kong/1/68 (H3N2) and А/ Hong Kong/4801/2014 (H3N2). The antiviral activity of ?Kagocel? substance was tested by its effect on the infectious titer of the influenza viruses and on its impact on the expression level of viral antigens in the enzyme immunoassay test system.
[h=4]RESULTS:[/h] ?Kagocel? substance had low toxicity for MDCK cells. ?Kagocel? inhibited the infection titer of influenza virus strains A/Puerto Rico/8/34 (H1N1), А/California/7/2009 (H1N1)pdm09, А/Hong Kong/1/68 (H3N2) and А/ Hong Kong /4801/2014 (H3N2) in the MDCK cell culture with equal efficacy. Study of the impact of ?Kagocel? substance on the expression level of viral antigens by ELISA also revealed its antiviral efficacy for all tested strains. Dose dependence was observed from concentration of substance and from infective dose of virus.
[h=4]DISCUSSION:[/h] Effective suppression of the reproduction of influenza virus strains A(H1N1), A(Н1N1)pdm09 and A(H3N2) in the different sublines of MDCK cells with ?Kagocel? was shown by the different methods. These results give the possibility to suggest that along with the ability to induce interferons, ?Kagocel? can impact on the reproduction of influenza virus, but the further research is needed.
[h=4]CONCLUSION:[/h] ?Kagocel? substance effectively inhibits the reproduction of influenza virus strains A(H1N1), A(Н1N1)pdm09 and A(H3N2) in vitro. At the same time, the selectivity index is quite high.


[h=4]KEYWORDS:[/h] Kagocel; in vitro; influenza; virus

PMID: 31622059 DOI: 10.18821/0507-4088-2019-64-3-125-131
 
Back
Top Bottom